{"id":"W2052918602","doi":"10.1016/j.cjca.2013.03.002","title":"Adopting the New Anticoagulants: All Aboard or All in Good Time?","year":2013,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; University of British Columbia","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Warfarin; Dabigatran; Atrial fibrillation; Anticoagulant; Dosing; Intensive care medicine; Medical prescription; Mandate; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002051594,0.0006169181,0.002806183,0.001481423,0.0006275908,0.002220233,0.001178826,0.002675206,0.003869832],"category_scores_gemma":[0.007096549,0.0003100126,0.001076658,0.002180707,0.0008241679,0.002715348,0.0006066302,0.003127146,0.0006605572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001206777,"about_ca_system_score_gemma":0.005327925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01103083,"about_ca_topic_score_gemma":0.03458418,"domain_scores_codex":[0.9987087,0.0003704231,0.0002941061,0.0001356984,0.0003892949,0.0001017549],"domain_scores_gemma":[0.9970223,0.001684032,0.0006209369,0.0000416631,0.0004499328,0.0001810353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001913511,0.0000894133,0.002201214,0.02349944,0.0007064892,0.0002448611,0.0001758782,0.0001674499,0.0002213041,0.003870815,0.05124729,0.9173845],"study_design_scores_gemma":[0.0005910712,0.0002618252,0.01327058,0.1092599,0.004029904,0.004084111,0.001338383,0.0003392691,0.0002820584,0.01113065,0.8552684,0.0001438116],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002067074,0.9939157,0.00005873902,0.004760321,0.0004165409,0.000002749845,0.00001352715,0.000002895021,0.0006228704],"genre_scores_gemma":[0.002904648,0.9926805,0.0002560868,0.002942312,0.0009406004,0.000005866521,0.00002601544,0.000001386324,0.0002424727],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01103083,"threshold_uncertainty_score":0.02193326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2055798416352259,"score_gpt":0.3907884538302043,"score_spread":0.1852086121949784,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}